[
  "Osman Kibar is the founder and CEO of San Diego-based biotech firm Samumed.",
  "Samumed raised $438 million in August 2018 to further its work developing drugs to reverse aging, claiming a valuation of $12.4 billion.",
  "The names of investors in the round were not disclosed.",
  "While getting a Ph.D. from the University of California, San Diego, he founded two companies, but did not have a management role at either.",
  "He then founded Samumed in 2008 in a Pfizer incubator, but had a falling out with the drug giant; Samumed now operates independent of Pfizer."
]